Thrombin Inhibition of the Lipoprotein Lipase System
- 1 November 1957
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 11 (3) , 450-454
- https://doi.org/10.1152/jappl.1957.11.3.450
Abstract
The blood coagulation enzyme, thrombin, has been found to act as a potent inhibitor of the lipoprotein lipase system. All other blood coagulation factors when tested individually were without inhibitory action. Analysis of our present knowledge of the physiological role of the lipoprotein lipase system suggests an atherogenic role for the thrombin inhibition phenomenon. Submitted on June 21, 1957Keywords
This publication has 8 references indexed in Scilit:
- EXPERIMENTAL ATHEROSCLEROSIS IN THE RAT1955
- Effect of Lipemia and Heparin on Free Fatty Acid Content of Rat Plasma.Experimental Biology and Medicine, 1954
- Lipoproteins, Coronary Heart Disease, and AtherosclerosisPhysiological Reviews, 1954
- In Vivo Effect of Anti-Heparin Agents on Serum Lipids and LipoproteinsAmerican Journal of Physiology-Legacy Content, 1954
- THE ENZYMATIC TRANSFORMATION OF LIPOPROTEINSJournal of Biological Chemistry, 1953
- Properties of Heparin-Produced Lipemia Clearing FactorAmerican Journal of Physiology-Legacy Content, 1952
- Analysis of the native heparin-lipoprotein complex including the identification of a heparin complement (heparin co-factor) obtained from extracts of tissue mast cellsBiochimica et Biophysica Acta, 1951
- Fat Absorption and AtherosclerosisScience, 1949